Dani joined Touchstone Innovations in January 2016 from Aravis, where as managing partner he co-led the design of the investment strategy, fund raising and investment process. He focuses on early stage, at times matching technologies with passionate management teams. His areas of investment have ranged from medical devices to protein therapeutics. Prior to Aravis, Dani worked at Index Ventures, helping build companies such as Acutus Medical, Levicept, and Versartis.
Dani holds a PhD in molecular biology from the University of Barcelona and an executive MBA from the Escuela de Organización Industrial (Madrid).